Selected article for: "cell surface and surface molecule"

Author: Martinez-Martin, Nadia
Title: Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
  • Document date: 2017_2_22
  • ID: 1giy1fow_22
    Snippet: Remarkably, many of the HAdV E3 proteins preferentially interacted with host receptors that exert known or predicted inhibitory functions during the immune response (as defined by the presence of intracellular immunoreceptor tyrosinebased inhibitory motif, ITIM), including LILRB1 [81, 82] , LAIR1 [83] , and MPZL1 [84] , suggesting previously unrecognized strategies of immunosuppression that may be utilized by other human pathogens [28] . Moreover.....
    Document: Remarkably, many of the HAdV E3 proteins preferentially interacted with host receptors that exert known or predicted inhibitory functions during the immune response (as defined by the presence of intracellular immunoreceptor tyrosinebased inhibitory motif, ITIM), including LILRB1 [81, 82] , LAIR1 [83] , and MPZL1 [84] , suggesting previously unrecognized strategies of immunosuppression that may be utilized by other human pathogens [28] . Moreover, several of the receptors identified as targets for the viral proteins in this study (including the prominent cell surface molecule CD45) do not have known counterreceptors in the host, supporting the longstanding hypothesis that pathogen molecules drive the evolution of immune receptors and in many instances may represent the most relevant modulators of host receptor function [85] [86] [87] . In summary, such unbiased, microarraybased study of immunomodulatory proteins represented the first large-scale analysis of the PPI landscape of a collection of extracellular immunomodulators encoded by viruses. Future investigation of other pathogen-encoded molecules using similar extracellular protein microarrays will likely shape our understanding of the pathogen imprint in our immune system.

    Search related documents:
    Co phrase search for related documents
    • cell surface and host receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell surface and human pathogen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cell surface and immune receptor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cell surface and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell surface and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell surface and immunomodulatory protein: 1
    • cell surface and inhibitory function: 1, 2, 3, 4, 5
    • cell surface molecule and host receptor: 1
    • cell surface molecule and immune response: 1
    • cell surface molecule and immune system: 1
    • extracellular protein microarray and immune system: 1
    • extracellular protein microarray and immunomodulatory protein: 1
    • future investigation and host receptor: 1
    • future investigation and human pathogen: 1
    • future investigation and immune receptor: 1
    • future investigation and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • future investigation and immune system: 1
    • host receptor and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • host receptor and inhibitory function: 1, 2